estrone has been researched along with estropipate in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (45.61) | 18.7374 |
1990's | 11 (19.30) | 18.2507 |
2000's | 6 (10.53) | 29.6817 |
2010's | 3 (5.26) | 24.3611 |
2020's | 11 (19.30) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Galbraith, D; Hackman, BW | 1 |
Bagdade, JD; Subbaiah, PV | 1 |
Aedo, AR; Diczfalusy, E; Landgren, BM | 1 |
Green, EM; Jennings, D; Katz-Karp, S; Lancaster, J; Notelovitz, M; Stoll, RW | 1 |
Aedo, AR; Diczfalusy, E; Landgren, BM; Le Donne, M | 1 |
Aedo, AR; Diczfalusy, E; Landgren, BM; Sundén, M | 1 |
Varma, TR | 2 |
Everard, D; Hole, D; Varma, TR | 1 |
Brown, AD; Bu'Lock, D; Butler, B; Faragher, B; Robinson, EL; Wilson, PD | 1 |
Garrett, D; Wren, B | 1 |
Aylward, M; Holly, F; Parker, RJ | 1 |
Barnard, GJ; Beard, RJ; Bishop, M; Collins, WP; Coppen, A | 1 |
Morsman, J; Varma, TR | 1 |
Crilly, RC; Oakey, RE; Towobola, OA | 1 |
Coope, J | 1 |
Brown, LB; Routledge, DA; Wren, BG | 1 |
Routledge, AD; Wren, BG | 1 |
Carlström, K; Lagrelius, A; Lunell, NO | 1 |
Coope, J; Poller, L; Thomson, JM | 1 |
Carignan, G; Lodge, BA; Skakum, W | 1 |
Johnson, P; Lagrelius, A; Lunell, NO; Samsioe, G | 1 |
King, RJ; Pryse-Davies, J; Ryder, TA; Townsend, PT; Whitehead, MI | 1 |
Nand, SL; Webster, MA; Wren, BG | 1 |
Burke, L; Golden, L; Wysowski, DK | 1 |
Daly, M; Friedman, AJ; Gleason, R; Juneau-Norcross, M; LeBoff, M; Rein, MS | 1 |
Zinser, JR | 1 |
Casper, RF; Chapdelaine, A | 1 |
Broverman, DM; Klaiber, EL; Peterson, LG; Snyder, MB; Vogel, W | 1 |
Doyle, MC; Feely, J; Harrison, RF; Wen, Y | 1 |
Harvey, PJ; Molloy, D; Savage, J; Wing, LM | 1 |
Alexandersen, P; Byrjalsen, I; Christiansen, C | 2 |
GODAL, HC | 1 |
Bhagat, CI; Criddle, RA; Dhaliwal, SS; Drury, PJ; Faulkner, DL; Gutteridge, DH; Holzherr, ML; Jamrozik, K; Kent, GN; Price, RI; Prince, RL; Retallack, RW; Stewart, GO; Stuckey, BG; Tran, L; Will, RK | 1 |
Adachi, JD; Muller, ME; Webber, CE | 1 |
Anstey, KJ; Christensen, H; Jorm, AF; Low, LF; Rodgers, B | 1 |
Greenberg, DL; Krishnan, RR; MacFall, JR; Payne, ME; Provenzale, JM; Steffens, DC | 1 |
Lisman, T | 1 |
Fancher, M; Marathe, P; Panfen, E; Shen, H; Sinz, M; Zhang, Y | 1 |
Barker, AB; Wagener, BM | 1 |
Pisoni, E; Van Dingenen, R | 1 |
Asakura, H; Ogawa, H | 1 |
Thierry, AR | 1 |
Ariëns, RAS; Kearney, KJ; Macrae, FL | 1 |
Medved, L; Weisel, JW | 1 |
Neerman-Arbez, M | 1 |
Fang, S; Shi, J; Wang, C; Wang, Y; Zuo, N | 1 |
Drobot, LB; Horak, IR; Hudkova, OO; Kishko, TO; Latyshko, NV; Tokarchuk, KO; Tykhomyrov, AA; Yusova, OI | 1 |
Beaulieu, JF; Cloutier, G; Khalfaoui, T; Perreault, N; Reyes Nicolas, V; Seltana, A; Teller, IC | 1 |
Hong, IH; Hwang, DH; Kang, C; Kim, E; Kim, JH; Kim, S; Prakash, RLM; Yang, HR | 1 |
3 review(s) available for estrone and estropipate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The Role of Fibrin(ogen) in Wound Healing and Infection Control.
Topics: Estrone; Fibrin; Fibrinogen; Humans; Infection Control; Wound Healing | 2022 |
The Story of the Fibrin(ogen) αC-Domains: Evolution of Our View on Their Structure and Interactions.
Topics: Estrone; Fibrin; Fibrinogen; Humans; Peptide Fragments; Polymers; Protein Structure, Tertiary; Thrombosis | 2022 |
20 trial(s) available for estrone and estropipate
Article | Year |
---|---|
Natural and synthetic oestrogens in the female climacteric.
Topics: Adult; Climacteric; Clinical Trials as Topic; Estradiol Congeners; Estrone; Ethinyl Estradiol; Female; Humans; Middle Aged; Piperazines | 1977 |
Replacement therapy and piperazine oestrone sulphate ('Harmogen') and its effect on memory.
Topics: Adult; Aged; Clinical Trials as Topic; Estrone; Female; Humans; Memory; Menopause; Middle Aged; Piperazines | 1976 |
Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women.
Topics: Administration, Oral; Biotransformation; Estradiol; Estrogens; Estrone; Female; Half-Life; Humans; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Random Allocation; Sex Hormone-Binding Globulin | 1990 |
Effect of cyclic estrone sulfate treatment on lipid profiles of postmenopausal women with elevated cholesterol levels.
Topics: Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Estrone; Female; Humans; Hypercholesterolemia; Menopause; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 1990 |
Effect of orally administered oestrogens on gonadotrophin levels in post-menopausal women.
Topics: Administration, Oral; Drug Combinations; Estradiol; Estriol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menopause; Middle Aged; Norgestrel; Random Allocation | 1989 |
Effect of orally administered oestrogens on circulating oestrogen profiles in post-menopausal women.
Topics: Administration, Oral; Drug Combinations; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Progesterone; Random Allocation | 1989 |
Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Estradiol Congeners; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Prospective Studies; Random Allocation; Urethra; Urinary Bladder; Urinary Incontinence, Stress; Urination | 1987 |
An evaluation of clinical response to piperazine oestrone sulphate ('Harmogen') in menopause patients.
Topics: Adult; Amenorrhea; Atrophy; Clinical Trials as Topic; Estradiol Congeners; Estrogens; Estrogens, Conjugated (USP); Estrone; Ethinyl Estradiol; Female; Humans; Menopause; Middle Aged; Piperazines; Placebos; Pruritus Vulvae; Time Factors; Vagina | 1974 |
Hysterectomy, hormones, and behaviour. A prospective study.
Topics: Clinical Trials as Topic; Double-Blind Method; Estrogens; Estrone; Female; Follow-Up Studies; Gonadotropins, Pituitary; Humans; Hysterectomy; Middle Aged; Piperazines; Prospective Studies; Random Allocation; Sexual Behavior | 1981 |
Is oestrogen therapy effective in the treatment of menopausal depression?
Topics: Adult; Clinical Trials as Topic; Depression; Double-Blind Method; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause; Middle Aged; Piperazines | 1981 |
The effect of type and dose of oestrogen on the blood pressure of post-menopausal women.
Topics: Antihypertensive Agents; Blood Pressure; Depression, Chemical; Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause | 1983 |
A double-blind cross-over study of piperazine oestrone sulphate and placebo with coagulation studies.
Topics: Blood Coagulation; Climacteric; Clinical Trials as Topic; Depression; Double-Blind Method; Estrone; Female; Humans; Piperazines | 1980 |
Continuous combined piperazine oestrone sulphate and medroxyprogesterone acetate hormone replacement therapy--a study of bleeding pattern, endometrial response, serum lipid and bone density changes.
Topics: Administration, Oral; Bone Density; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Pilot Projects; Uterine Hemorrhage | 1995 |
Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years.
Topics: Adult; Bone Density; Cholesterol, HDL; Delayed-Action Preparations; Estradiol Congeners; Estrone; Female; Hematocrit; Humans; Leiomyoma; Leuprolide; Middle Aged; Norethindrone; Prospective Studies; Time Factors; Uterine Neoplasms | 1994 |
Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women.
Topics: Affect; Blood Platelets; Climacteric; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Gonadal Steroid Hormones; Humans; Individuality; Middle Aged; Monoamine Oxidase; Norethindrone | 1996 |
The effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin-angiotensin system in normotensive postmenopausal women.
Topics: Administration, Oral; Aldosterone; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Double-Blind Method; Estrogen Replacement Therapy; Estrone; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Middle Aged; Postmenopause; Renin; Renin-Angiotensin System; Sex Hormone-Binding Globulin | 1999 |
Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium.
Topics: Administration, Oral; Endometrium; Estrone; Female; Hormone Replacement Therapy; Humans; Norethindrone; Postmenopause; Progesterone Congeners; Prospective Studies; Uterine Hemorrhage | 2000 |
Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects.
Topics: Aged; Bone Density; Climacteric; Drug Therapy, Combination; Estrone; Female; Humans; Lipoproteins; Middle Aged; Norethindrone; Progesterone Congeners; Prospective Studies | 2000 |
A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density.
Topics: Absorptiometry, Photon; Aged; Biomarkers; Bone Density; Calcitriol; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Hip Joint; Humans; Hydroxyproline; Medroxyprogesterone Acetate; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Quality of Life; Severity of Illness Index; Single-Blind Method; Spinal Fractures; Treatment Outcome | 2003 |
Hormone replacement therapy improves distal radius bone structure by endocortical mineral deposition.
Topics: Absorptiometry, Photon; Aged; Bone and Bones; Bone Density; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone; Middle Aged; Minerals; Osteoporosis, Postmenopausal; Prospective Studies; Radius | 2003 |
34 other study(ies) available for estrone and estropipate
Article | Year |
---|---|
Conjugated oestrogens.
Topics: Animals; Carcinogens; Chemical Phenomena; Chemistry; Equilin; Estrogens, Conjugated (USP); Estrone; Female; Humans; Male; Piperazines; Rats | 1979 |
Effects of estropipate treatment on plasma lipids and lipoprotein lipid composition in postmenopausal women.
Topics: Cholesterol; Cholesterol Esters; Estrone; Female; Humans; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, HDL2; Lipoproteins, HDL3; Lipoproteins, LDL; Lipoproteins, VLDL; Menopause; Middle Aged; Triglycerides | 1991 |
Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Topics: Aged; Atrophy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hyperplasia; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progestins; Time Factors | 1985 |
Effect of natural estrogen on the serum level of follicle-stimulating hormone (FSH), estradiol and estrone in post-menopausal women and its effect on endometrium.
Topics: Aged; Endometrium; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Humans; Menopause; Middle Aged | 1985 |
The effect of low-dose piperazine oestrone sulphate and low-dose levonorgestrel on blood lipid levels in post-menopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Estrone; Female; Humans; Levonorgestrel; Lipids; Menopause; Middle Aged; Norgestrel | 1985 |
Effect of oestrogen and progesterone on fasting serum cholesterol and triglyceride levels in post-menopausal women.
Topics: Adult; Aged; Cholesterol; Clonidine; Dydrogesterone; Estradiol; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Triglycerides | 1982 |
Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral, Combined; Estradiol; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progesterone Congeners; Time Factors | 1983 |
Oestrone sulphate in plasma from postmenopausal women and the effects of oestrogen and androgen therapy.
Topics: Adrenal Cortex Hormones; Adult; Aged; Castration; Dehydroepiandrosterone; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Male; Menopause; Middle Aged; Piperazines | 1980 |
Differential clinical response to oestrogens after menopause.
Topics: Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause | 1982 |
Treatment with oral estrone sulphate in the female climacteric. II. Hormonal aspects.
Topics: Adult; Climacteric; Dehydroepiandrosterone; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Menopause; Middle Aged; N-Methylscopolamine; Piperazines; Scopolamine Derivatives | 1981 |
Analysis of piperazine estrone sulfate in tablets by ion-pair high-performance liquid chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Estrone; Piperazines; Tablets | 1982 |
Treatment with oral estrone sulphate in the female climacteric. I. Influence on lipids.
Topics: Adult; Cholesterol; Climacteric; Estrone; Fatty Acids; Female; Humans; Lipids; Lipoproteins; Menopause; Middle Aged; Phosphatidylcholines; Piperazines; Triglycerides | 1981 |
Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium.
Topics: DNA; Dose-Response Relationship, Drug; Endometrium; Estradiol; Estradiol Congeners; Estradiol Dehydrogenases; Estrogens; Estrone; Female; Humans; Isocitrate Dehydrogenase; Menopause; Norethindrone; Norgestrel; Piperazines; Progestins; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone | 1981 |
Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992.
Topics: Administration, Cutaneous; Administration, Intravaginal; Administration, Oral; Adult; Aged; Aged, 80 and over; Androgens; Drug Prescriptions; Drug Therapy, Combination; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Menopause; Middle Aged; United States | 1995 |
Clarification for formulation of estropipate (Ogen)
Topics: Estradiol Congeners; Estrone | 1994 |
Estrogen and interrupted progestin: a new concept for menopausal hormone replacement therapy.
Topics: Adult; Blood Pressure; Body Weight; Climacteric; Drug Therapy, Combination; Endometrium; Estradiol Congeners; Estrogen Replacement Therapy; Estrone; Female; Humans; Lipids; Menopause; Menstruation; Middle Aged; Patient Compliance; Pilot Projects; Progestins | 1993 |
The effect of hormone replacement therapy on vitamin E status in postmenopausal women.
Topics: Antioxidants; Arteriosclerosis; Cell Membrane; Chromatography, High Pressure Liquid; Contraceptives, Oral; Erythrocytes; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Follow-Up Studies; Humans; Incidence; Lipids; Lipoproteins, LDL; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Vitamin E | 1997 |
Binding of heparin to fibrin(ogen).
Topics: Estrone; Fibrin; Fibrinogen; Heparin; Humans | 1961 |
NEW and nonofficial remedies: piperazine estrone sulfate.
Topics: Estrone; Piperazines | 1952 |
Hormone replacement therapy and cognition in an Australian representative sample aged 60-64 years.
Topics: Analysis of Variance; Australia; Cognition; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hysterectomy; Middle Aged; Neuropsychological Tests; Postmenopause; Reaction Time | 2006 |
Differences in brain volumes among males and female hormone-therapy users and nonusers.
Topics: Aged; Brain; Cognition; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Health Status; Humans; Magnetic Resonance Imaging; Male; Medroxyprogesterone Acetate; Neuropsychological Tests | 2006 |
SULESTREX.
Topics: Climacteric; Estrogens; Estrone; Female; Menopause | 1952 |
EFFECTIVE estrogenic therapy with sulestrex. . . for menopause and suppression of lactation.
Topics: Climacteric; Estrogens; Estrone; Female; Humans; Lactation; Menopause | 1952 |
Crosslinked clots formed independently of factor XIII and without fibrinogen-to-fibrin conversion - is this a liver-specific phenomenon?
Topics: Estrone; Factor XIII; Fibrin; Fibrinogen; GTP-Binding Proteins; Humans; Liver; Protein Glutamine gamma Glutamyltransferase 2; Transglutaminases | 2019 |
Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate.
Topics: Animals; Biological Transport; Cell Line; Drug Interactions; Estrone; Hepatocytes; Humans; Isoquinolines; Macaca fascicularis; Organic Anion Transporters; Organic Cation Transport Proteins; Organic Cation Transporter 1; Rosuvastatin Calcium; Solute Carrier Organic Anion Transporter Family Member 1B3; Sulfonamides; Tandem Mass Spectrometry | 2019 |
An Ounce of Prevention May Prevent Hospitalization.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Estrone; Fibrinolysin; Hospitalization; Humans; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2 | 2020 |
Comment to the paper "Assessing nitrogen dioxide (NO
Topics: Air Pollutants; Air Pollution; Betacoronavirus; Coronavirus; Coronavirus Infections; COVID-19; Estrone; Humans; Nitrogen Dioxide; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Consideration of Tranexamic Acid Administration to COVID-19 Patients.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Estrone; Fibrinolysin; Humans; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Tranexamic Acid | 2020 |
Anti-protease Treatments Targeting Plasmin(ogen) and Neutrophil Elastase May Be Beneficial in Fighting COVID-19.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Estrone; Fibrinolysin; Humans; Leukocyte Elastase; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2 | 2020 |
When fibrin(ogen) is too loud, silence it!
Topics: Estrone; Fibrin; Fibrinogen | 2022 |
CD44-fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition.
Topics: Animals; Estrone; Fibrin; Fibrinogen; Hemorrhage; Leukemia, Promyelocytic, Acute; Mice | 2022 |
ADAPTOR PROTEIN Ruk/CIN85REGULATES REDOX BALANCE IN 4T1MOUSE BREAST CANCER CELLS EXPOSED TO PLASMIN(OGEN).
Topics: Adaptor Proteins, Signal Transducing; Animals; Breast Neoplasms; Estrone; Female; Fibrinolysin; Glutathione Peroxidase; Hydrogen Peroxide; Mice; Oxidation-Reduction; Plasminogen; Reactive Oxygen Species | 2022 |
Fibrin(ogen) Is Constitutively Expressed by Differentiated Intestinal Epithelial Cells and Mediates Wound Healing.
Topics: Animals; Epithelial Cells; Estrone; Fibrin; Fibrinogen; Inflammation; Intestines; Mice; Phosphatidylinositol 3-Kinases; Wound Healing | 2022 |
Exploring the Fibrin(ogen)olytic, Anticoagulant, and Antithrombotic Activities of Natural Cysteine Protease (Ficin) with the κ-Carrageenan-Induced Rat Tail Thrombosis Model.
Topics: Animals; Anticoagulants; Carrageenan; Cysteine Proteases; Estrone; Fibrin; Fibrinogen; Fibrinolytic Agents; Ficain; Rats; Rats, Sprague-Dawley; Thrombosis | 2022 |